- Stocks
- Healthcare
- NYSE: TMO

Price (delayed)

$573.63

Market cap

$224.98B

P/E Ratio

31.97

Dividend/share

$1.2

EPS

$17.94

Enterprise value

$251.22B

Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry .

The company's equity rose by 13% YoY and by 3% QoQ

Thermo Fisher Scientific's revenue has increased by 13% YoY and by 3.1% from the previous quarter

Thermo Fisher Scientific's quick ratio has plunged by 58% YoY but it has increased by 8% from the previous quarter

The debt has increased by 34% YoY but it has decreased by 3.6% QoQ

Thermo Fisher Scientific's net income has decreased by 18% YoY and by 5% from the previous quarter

TMO's EPS is down by 17% year-on-year and by 5% since the previous quarter

What are the main financial stats of TMO

Market
Valuations
Earnings

Shares outstanding

392.2M

Market cap

$224.98B

Enterprise value

$251.22B

Price to earnings (P/E)

31.97

Price to book (P/B)

5.16

Price to sales (P/S)

5.09

EV/EBIT

29.97

EV/EBITDA

21.66

EV/Sales

5.69

Revenue

$44.17B

EBIT

$8.38B

EBITDA

$11.6B

Free cash flow

$5.63B

Per share
Balance sheet
Liquidity

EPS

$17.94

Free cash flow per share

$14.36

Book value per share

$111.15

Revenue per share

$112.67

TBVPS

$82.23

Total assets

$90.54B

Total liabilities

$46.93B

Debt

$29.16B

Equity

$43.55B

Working capital

$8.18B

Debt to equity

0.67

Current ratio

1.74

Quick ratio

0.95

Net debt/EBITDA

2.26

Margins
Efficiency
Dividend

EBITDA margin

26.3%

Gross margin

44.4%

Net margin

15.9%

Operating margin

20.5%

Return on assets

7.6%

Return on equity

16.8%

Return on invested capital

17.1%

Return on capital employed

10.6%

Return on sales

19%

Dividend yield

0.21%

DPS

$1.2

Payout ratio

6.7%

How has the Thermo Fisher Scientific stock price performed over time

Intraday

-0.65%

1 week

-3.37%

1 month

5.17%

1 year

3.59%

YTD

4.17%

QTD

4.17%

How have Thermo Fisher Scientific's revenue and profit performed over time

Revenue

$44.17B

Gross profit

$19.62B

Operating income

$9.07B

Net income

$7.03B

Gross margin

44.4%

Net margin

15.9%

The net margin has decreased by 27% YoY and by 9% QoQ

Thermo Fisher Scientific's operating margin has decreased by 24% YoY and by 9% from the previous quarter

Thermo Fisher Scientific's net income has decreased by 18% YoY and by 5% from the previous quarter

The operating income has contracted by 14% YoY and by 6% from the previous quarter

What is Thermo Fisher Scientific's growth rate over time

What is Thermo Fisher Scientific stock price valuation

P/E

31.97

P/B

5.16

P/S

5.09

EV/EBIT

29.97

EV/EBITDA

21.66

EV/Sales

5.69

TMO's EPS is down by 17% year-on-year and by 5% since the previous quarter

The stock's price to earnings (P/E) is 4.8% more than its last 4 quarters average of 30.5

The company's equity rose by 13% YoY and by 3% QoQ

The P/B is 12% above the 5-year quarterly average of 4.6 but 4.4% below the last 4 quarters average of 5.4

Thermo Fisher Scientific's revenue has increased by 13% YoY and by 3.1% from the previous quarter

The P/S is 7% below the last 4 quarters average of 5.5 but 3.9% above the 5-year quarterly average of 4.9

How efficient is Thermo Fisher Scientific business performance

TMO's return on invested capital is down by 45% year-on-year and by 12% since the previous quarter

TMO's ROA is down by 39% YoY and by 11% from the previous quarter

The ROE has contracted by 29% YoY and by 8% from the previous quarter

TMO's ROS is down by 29% year-on-year and by 10% since the previous quarter

What is TMO's dividend history

DPS

$1.2

Dividend yield

0.21%

Payout ratio

6.7%

Recent dividends

How did Thermo Fisher Scientific financials performed over time

The total assets is 93% greater than the total liabilities

Thermo Fisher Scientific's quick ratio has plunged by 58% YoY but it has increased by 8% from the previous quarter

The current ratio has declined by 45% year-on-year but it has increased by 5% since the previous quarter

The debt is 33% lower than the equity

The debt has increased by 34% YoY but it has decreased by 3.6% QoQ

Thermo Fisher Scientific's debt to equity has increased by 20% YoY but it has decreased by 7% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.